Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis

Xue, C; Yang, B; Xu, J; Zhou, CC; Zhang, LM; Gao, X; Dai, B; Yu, SQ; Mao, ZG; Mei, CL; Xu, CG

Xu, CG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Kidney Inst, Div Nephrol,CPLA Chinese Peoples Liberat Army, Shanghai, Peoples R China.; Xu, CG (corresponding author), Second Mil Med Univ, Affiliated Hosp 3, Dept Nephrol, Shanghai, Peoples R China.

CLINICAL KIDNEY JOURNAL, 2021; 14 (4): 1042

Abstract

Background. The efficacy and safety of rituximab (RTX) in adult frequent-relapsing (FR) or steroid-dependent (SD) nephrotic syndrome (NS), including m......

Full Text Link